These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16410527)

  • 1. Responsiveness of the shoulder function assessment scale in patients with rheumatoid arthritis.
    Vermeulen HM; Breedveld FC; Le Cessie S; Rozing PM; van den Ende CH; Vliet Vlieland TP
    Ann Rheum Dis; 2006 Feb; 65(2):239-41. PubMed ID: 16410527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis.
    Salaffi F; Stancati A; Carotti M
    Clin Rheumatol; 2002 Nov; 21(6):478-87. PubMed ID: 12447631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tightly controlled disease activity possible with online patient-reported outcomes?
    Walter MJ; Mohd Din SH; Hazes JM; Lesaffre E; Barendregt PJ; Luime JJ
    J Rheumatol; 2014 Apr; 41(4):640-7. PubMed ID: 24532833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shoulder function and active motion deficit in patients with rheumatoid arthritis.
    Slungaard B; Mengshoel AM
    Disabil Rehabil; 2013 Aug; 35(16):1357-63. PubMed ID: 23116340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability, validity and responsiveness of a new leisure index: the Patient-Specific Leisure Scale (PSLS).
    Wikström I; Arvidsson B; Nilsson K; Roos E; Jacobsson LT
    Musculoskeletal Care; 2009 Sep; 7(3):178-93. PubMed ID: 19191254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis.
    Uhlig T; Moe R; Reinsberg S; Kvien TK; Cieza A; Stucki G
    Ann Rheum Dis; 2009 Jun; 68(6):879-84. PubMed ID: 18625628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
    Eberhardt K; Sandqvist G; Geborek P
    Scand J Rheumatol; 2008; 37(2):109-12. PubMed ID: 18415767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination.
    Heald AE; Fudman EJ; Anklesaria P; Mease PJ;
    J Rheumatol; 2010 May; 37(5):1042-8. PubMed ID: 20231202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    J Rheumatol; 1996 Jan; 23(1):52-60. PubMed ID: 8838508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of shoulder function in rheumatoid arthritis.
    van Den Ende CH; Rozing PM; Dijkmans BA; Verhoef JA; Voogt-van der Harst EM; Hazes JM
    J Rheumatol; 1996 Dec; 23(12):2043-8. PubMed ID: 8970039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Kaur L; Sharma S
    Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disabilities of importance for patients to improve--using a patient preference tool in rheumatoid arthritis.
    Alemo Munters L; Brodin N; Löfberg E; Stråt S; Alexanderson H
    Disabil Rehabil; 2014; 36(21):1762-7. PubMed ID: 24364534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments.
    Hagen KB; Smedstad LM; Uhlig T; Kvien TK
    J Rheumatol; 1999 Jul; 26(7):1474-80. PubMed ID: 10405932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness of the Michigan Hand Outcomes Questionnaire--Dutch language version in patients with rheumatoid arthritis.
    van der Giesen FJ; Nelissen RG; Arendzen JH; de Jong Z; Wolterbeek R; Vliet Vlieland TP
    Arch Phys Med Rehabil; 2008 Jun; 89(6):1121-6. PubMed ID: 18503809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
    Pincus T; Bergman MJ; Yazici Y; Hines P; Raghupathi K; Maclean R
    Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial.
    Le Loët X; Nordström D; Rodriguez M; Rubbert A; Sarzi-Puttini P; Wouters JM; Woolley JM; Wright N; Lawrence C; Appleton B
    J Rheumatol; 2008 Aug; 35(8):1538-44. PubMed ID: 18634163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of joint mobility in rheumatoid arthritis trials: the value of the EPM-range of motion scale.
    Vliet Vlieland TP; van den Ende CH; Breedveld FC; Hazes JM
    J Rheumatol; 1993 Dec; 20(12):2010-4. PubMed ID: 8014926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.